Dellora Investments Master Fund LP 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-15 4:14 pm Purchase | 2025-01-08 | 13G | Tenax Therapeutics, Inc. TENX | Dellora Investments Master Fund LP | 351,071 10.300% | 116,278 (+49.52%) | Filing |
| 2024-12-05 1:47 pm Purchase | 2024-11-27 | 13G | Tenax Therapeutics, Inc. TENX | Dellora Investments Master Fund LP | 234,793 6.900% | 234,793 (New Position) | Filing |